Deutsche Bank
OPTR

Deutsche Bank’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Deutsche Bank’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-75,820
Closed -$954K – 6087
2013
Q3 		$954K Sell
75,820
-265,643
-78% -$3.52M ﹤0.01% 3009
2013
Q2 		$4.94M Buy
+341,463
New +$4.97M ﹤0.01% 1617

Deutsche Bank's OPTR Position: Q4 2013 in Review

Deutsche Bank sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 75,820 shares — an estimated $954K sold.

Deutsche Bank first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $4.94M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Deutsche Bank reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Deutsche Bank sold 75,820 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $954K.
  • Deutsche Bank first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Deutsche Bank's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $4.94M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Deutsche Bank's 13F filing for Q4 2013, filed 18 Feb 2014.